Return On Equity of Estrella Immunopharma, Inc. from 31 Dec 2021 to 30 Sep 2024

Taxonomy & unit: ratio: %
Description: Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary: Estrella Immunopharma, Inc. quarterly and annual Return On Equity in % history and change rate from 31 Dec 2021 to 30 Sep 2024.
Estrella Immunopharma, Inc. Return On Equity for the quarter ending 30 Sep 2024 was -156%, a 191% decline year-over-year.
Estrella Immunopharma, Inc. annual Return On Equity for 2024 was -92%, a 164% decline from 2023.
Estrella Immunopharma, Inc. annual Return On Equity for 2023 was 143%, a 347% increase from 2022.
Estrella Immunopharma, Inc. annual Return On Equity for 2022 was 32%, a 41% decline from 2021.

Return On Equity, Quarterly (%)

Return On Equity, YoY Quarterly Change (%)

Return On Equity, Annual (%)

Return On Equity, YoY Annual Change (%)

Estrella Immunopharma, Inc. Quarterly Return On Equity (%)

Period	Value	YoY Chg	Change %	Start Date	End Date
Q3 2024	-156%	-329%	-191%	01 Jul 2024	30 Sep 2024
Q2 2024	-92%	-200%	-184%	01 Apr 2024	30 Jun 2024
Q1 2024	-87%	-258%	-151%	01 Jan 2024	31 Mar 2024
Q4 2023	1313%	+1116%	+567%	01 Oct 2023	31 Dec 2023
Q3 2023	172%	-28%	-14%	01 Jul 2023	30 Sep 2023
Q2 2023	109%	+35%	+48%	01 Apr 2023	30 Jun 2023
Q1 2023	171%	+119%	+231%	01 Jan 2023	31 Mar 2023
Q4 2022	197%	+143%	+264%	01 Oct 2022	31 Dec 2022
Q3 2022	201%			01 Jul 2022	30 Sep 2022
Q2 2022	73%			01 Apr 2022	30 Jun 2022
Q1 2022	52%			01 Jan 2022	31 Mar 2022
Q4 2021	54%			01 Oct 2021	31 Dec 2021

Period	Value	YoY Chg	Change %	Start Date	End Date
2024	-92%	-234%	-164%	01 Jul 2023	30 Jun 2024
2023	143%	+111%	+347%	01 Jul 2022	30 Jun 2023
2022	32%	-22%	-41%	01 Jan 2022	31 Dec 2022
2021	54%			06 Jan 2021	31 Dec 2021

* An asterisk sign (*) next to the value indicates that the value is likely invalid.